Biomarkers are likely to be important in the study of Alzheimer disease (AD) for a variety of reasons. A clinical diagnosis of Alzheimer disease is inaccurate even among experienced investigators in about 10% to 15% of cases, and biomarkers might improve the accuracy of diagnosis.
Biomarkers are the measures used to perform a clinical assessment such as blood pressure or cholesterol level and are used to monitor and predict health states in individuals or across populations so that appropriate therapeutic intervention can be planned.
Biomarkers are used to predict serious illnesses such as diabetes and cardiovascular disease. Each individual biomarker indicates whether there is a disease or health state and can be combined to provide a detailed picture of how healthy a person is and whether or not a diagnosis needs to be made.
Related Journals of Biomarkers in Clinical Trials
Clinical Research & Bioethics Open Access, Clinical & Experimental Pathology, Clinical Case Reports, Contemporary Clinical Trials, Journal of Cancer Science & Therapy,Translational Medicine, International Journal of Clinical Trials, PLOS Clinical Trials,Controlled Clinical Trials, Clinical Trials and Practice Open Journal.